New tech is being developed which could help the world become more proactive to the outbreak of viruses.
Octavia is an AI, created by Apriori Bio, which combines experimental biology with algorithms to create synthetic variants of a given virus and tests how likely they are to escape vaccines. The biotech can then reverse the process to design vaccines and antibodies based on the AI data.
Octavia will test how the synthetic virus variants it creates bind to antibodies to design more effective virus protection.
Apriori Bio was founded during the COVID pandemic and aims to tackle multiple ‘ultra dynamic’ viruses outside of SARS-CoV-2 including flu and HIV in an effort to be better prepared for annual virus outbreaks. It features a number of ex-US government leaders on its advisory board including a former commissioner and vaccine official from the FDA, a former vaccine strategist from Moderna and a former assistant secretary of defense from the Obama administration.
COREX Logistics is a supply and logistics company with headquarters in Ireland, working with pharma and patients to facilitate improved healthcare worldwide.
Our expert international team works across an 80-country network, specialising in the EMEA region, providing the latest in clinical trial logistics technology and systems, cold-chain delivery, temperature-controlled transportation and storage services. From sourcing, procurement and customs clearance, to labelling, returns and destruction, we cover every link in the supply chain. We also run an established Named Patient Programme and provide Patient-Oriented services. With extensive knowledge and on-the-ground insight into our markets, we create innovative solutions with the ultimate goal of improving the lives of patients.